Atacicept is a blast from the very long ago (in biotech terms) past. ZGEN was a long time ago. I even remember their headquarters in Seattle, back when Seattle was a biotech center.
Atacicept seems to work well in the renal disease space, but it’s blown up in the past on safety for some indications. So that seems the big risk?